Blankenberg, Francis G <br/><br/>
Targeted systemic radiotherapy with scVEGF/177Lu leads to sustained disruption of the tumor vasculature and intratumoral apoptosis.  [electronic resource] 

 -  Journal of nuclear medicine : official publication, Society of Nuclear Medicine  Oct 2011 
 - 1630-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1535-5667 
<br/><br/><label>Standard No.: </label>10.2967/jnumed.111.091629  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--therapeutic use<br/>Animals<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Apoptosis--radiation effects<br/>Bevacizumab<br/>Breast Neoplasms--blood supply<br/>Cell Line, Tumor<br/>Cell Survival--radiation effects<br/>Combined Modality Therapy<br/>Endothelial Cells--radiation effects<br/>Female<br/>Humans<br/>Indoles--therapeutic use<br/>Lutetium--pharmacokinetics<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred ICR<br/>Mice, SCID<br/>Neovascularization, Pathologic--radiotherapy<br/>Pyrroles--therapeutic use<br/>Radioisotopes--pharmacokinetics<br/>Radiopharmaceuticals--pharmacokinetics<br/>Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors<br/>Sunitinib<br/>Vascular Endothelial Growth Factor A--pharmacokinetics